Channeling health economics research initiatives to improve decision-making processes in the EU F. AntonanzasR. Rodríguez-Ibeas Editorial 11 April 2013 Pages: 847 - 852
Cost-effectiveness analysis of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn’s disease Monia MarchettiNicola L. LiberatoGino R. Corazza Original Paper 14 September 2012 Pages: 853 - 861
The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice Ingrid LekanderFredrik BorgströmGisela Kobelt Original Paper 19 September 2012 Pages: 863 - 873
Patients’ access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries P. A. LairesF. ExpostoJ. E. Fonseca Original Article 18 September 2012 Pages: 875 - 885
The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies Jen KrugerAlan Brennan Original Paper 18 October 2012 Pages: 887 - 899
Internal validation of models with several interventions Afschin GandjourAmiram Gafni Original Paper 03 November 2012 Pages: 901 - 909
Quantifying short run cost-effectiveness during a gradual implementation process Gijs van de WeteringWillem H. WoertmanEddy M. M. Adang Original Paper 27 October 2012 Pages: 911 - 918
Explaining length of stay variation of episodes of care in the Netherlands Siok Swan TanLeona Hakkaart-van RoijenW. Ken Redekop Original Paper 21 October 2012 Pages: 919 - 927
Managing for efficiency in health care: the case of Greek public hospitals Panagiotis MitropoulosIoannis MitropoulosAris Sissouras Original Paper 31 October 2012 Pages: 929 - 938
Treatment costs of attention deficit hyperactivity disorder in Germany Sebastian BraunJan ZeidlerWolfgang Greiner Original Paper 21 November 2012 Pages: 939 - 945
Targeted screening for Coeliac Disease among irritable bowel syndrome patients: analysis of cost-effectiveness and value of information Leyla MohseninejadTalitha FeenstraErik Buskens Original Paper 18 November 2012 Pages: 947 - 957
The impact of generic reference pricing in Italy, a decade on Simone GhislandiPatrizio ArmeniClaudio Jommi Original Paper 25 November 2012 Pages: 959 - 969
Maximal endurable time states and the standard gamble: more preference reversals P. F. M. StalmeierA. L. Verheijen Original Paper 09 December 2012 Pages: 971 - 977
How efficient are Greek hospitals? A case study using a double bootstrap DEA approach Kostas KounetasFotis Papathanassopoulos Original Paper 11 December 2012 Pages: 979 - 994
Cost-effectiveness analysis, prevention of atopic dermatitis by oral application of bacterial lysate in newborns/small children Peter KienckeKristina ViehmannReinhard Rychlik Original Paper 15 December 2012 Pages: 995 - 1002
Long-term health investment when people underestimate their adaptation to old age-related health problems Octave JokungSerge Macé Original Paper 28 December 2012 Pages: 1003 - 1013
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany Bernhard UltschIngrid KösterOle Wichmann Original Paper 28 December 2012 Pages: 1015 - 1026
TIPP and Lichtenstein modalities for inguinal hernia repair: a cost minimisation analysis alongside a randomised trial G. G. KoningE. M. M. AdangC. J. H. M. van Laarhoven Original Paper 28 December 2012 Pages: 1027 - 1034
Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation Björn StollenwerkAfschin GandjourUwe Siebert Original Paper 30 December 2012 Pages: 1035 - 1048